Condensed heterocyclic pyrazole derivatives as kinase...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 495/04 (2006.01) A61K 31/4162 (2006.01) C07D 231/00 (2006.01) C07D 333/04 (2006.01) C07D 487/04 (2006.01) C07D 491/04 (2006.01)

Patent

CA 2493680

Bicyclo-pyrazole compound of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, processes for their preparation, combinatorial libraries comprising a plurality of them and pharmaceutical compositions thereof, are herewith disclosed: the compounds of the invention are useful, in therapy, as protein kinase inhibitors, for instance in the treatment of cancer.

La présente invention concerne un composé bicyclo-pyrazolique représenté par la formule (I) et certains de ses sels pharmaceutiquement admis, conformément à la définition qu'en donne la spécification. L'invention concerne également des procédés permettant son élaboration, des échantillothèques combinatoires en comprenant une pluralité, et des compositions pharmaceutiques réalisées à partir de ces composés. Les composés de l'invention conviennent, à des fins thérapeutiques, comme inhibiteurs de protéines kinases, notamment pour le traitement du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Condensed heterocyclic pyrazole derivatives as kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Condensed heterocyclic pyrazole derivatives as kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Condensed heterocyclic pyrazole derivatives as kinase... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1895647

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.